|
|
|
|
|
|
By Dan Schell, chief editor, Clinical Leader | It’s one thing to implement RBM (risk-based monitoring) components like central monitoring or initial risk assessments, but if you’re still doing 100% SDR/SDV, you’re not maximizing the benefits of this approach. So what’s the holdup? | |
|
|
|
| Overcoming Issues Of Non-Enrolling Sites In Clinical Trials | White Paper | By Dave Hiltbrand and Dave Berry, Thermo Fisher Scientific | Explore the challenges of non-enrolling sites in clinical trials, focusing on the benefits of leveraging artificial intelligence (AI) and machine learning (ML) in addressing those issues. |
|
|
| Why Now Is The Right Time To Adopt eConsent | Article | By Kate Yawman, Advarra | As much as eConsent helps staff, participants are also likely to prefer it over traditional paper methods. Explore the benefits of eConsent and some strategic steps sites can take right now to adopt the process. |
|
|
| Bring Your Own Device (BYOD) Clinical Trials | Article | Crucial Data Solutions | Bring Your Own Device (BYOD) is revolutionizing clinical trials by enabling participants and researchers to use their own smartphones, tablets, or computers to collect and manage data. |
|
|
|
|
| Evidence Of An Industry's Readiness To Collaborate | Poster | By Aruna Adhikari, IQVIA Technologies | The effort to build a single home for sites to access their trial systems has demonstrated that the industry is ready to forego competitive discourse to deliver benefits to sites and patients. |
|
|
